Browse the evidence

Positive Airway Pressure (PAP) therapy is the primary medical treatment for Obstructive Sleep Apnea (OSA) and significantly reduces daytime sleepiness and apnea-hypopnea index (AHI), though its impact on cardiovascular mortality and hard endpoints remains less definitive.

If you have OSA, PAP therapy is the most effective way to keep your airway open and reduce sleepiness. You need to find the right pressure and mask type, which may take some trial and error, but sticking with it is crucial for your long-term health and quality of life.

Surgical interventions and oral appliances are alternative treatments for OSA, with efficacy varying by patient anatomy and severity, often serving as options when PAP is not tolerated.

If PAP doesn't work for you, talk to your doctor about surgical options or oral appliances. These can be effective for some people, especially if your anatomy is suitable, but they require careful evaluation.

Mendelian randomization using semiparametric methods (fractional polynomial or piecewise linear) reveals that the causal relationship between BMI and systolic blood pressure is nonlinear, showing a steep increase up to a BMI of ~32 kg/m2 and a flatter or slightly negative slope thereafter, while the relationship with diastolic blood pressure increases almost linearly up to ~40 kg/m2.

For individuals with a BMI between 25 and 32, blood pressure tends to rise sharply with each unit of BMI. However, once BMI exceeds 32, the rate of blood pressure increase may slow down or even slightly decrease, suggesting a complex biological interaction rather than a simple linear progression. For Diastolic Blood Pressure, the increase remains relatively linear up to a BMI of 40. This implies that weight management strategies might have different impacts on blood pressure depending on the starting BMI and the type of blood pressure being monitored.

Iron status has a dual role in immunity: deficiency impairs immune cell function (B-cells, T-cells), but excess iron during infection can be exploited by pathogens, leading to an evolutionary mechanism of hypoferremia (iron withdrawal) during acute infection.

Maintain healthy iron levels through diet (red meat, beans, leafy greens) to support immune cell function. However, if you have a serious active infection (like malaria or TB) or a condition like hemochromatosis, consult your doctor before taking iron supplements, as excess iron can help pathogens grow. The body naturally restricts iron during infection (hypoferremia) to fight this.

Genetic factors, particularly polymorphisms affecting neurotransmitter systems (dopamine, serotonin) and metabolic traits (BMI, insulin resistance), significantly increase the risk of developing eating disorders, with distinct genetic architectures for anorexia nervosa versus binge-type disorders.

If you have a family history of eating disorders, you may have a biological predisposition. This is not your fault, but it is a risk factor you can manage. Focus on early identification of symptoms and seek professional support if you notice changes in eating habits or body image, as genetic risk can be mitigated by environmental factors.

Childhood trauma, abuse, and neglect are strongly linked to the development of eating disorders, particularly Bulimia Nervosa and Binge Eating Disorder, through interactions with genetic susceptibility.

If you have experienced childhood trauma, you may be at higher risk for eating disorders. This risk is not inevitable, but it is significant. Trauma-informed therapy and support can help address the underlying emotional pain that may manifest as disordered eating.

Pharmacological inhibition of BCKDK using BT2 reduces plasma branched-chain amino acid (BCAA) and branched-chain alpha-keto acid (BCKA) levels, thereby attenuating obesity-associated insulin resistance in obese mice.

In obese individuals, high levels of branched-chain amino acids (BCAAs) and their metabolites contribute to insulin resistance. This study suggests that enhancing the body's ability to break down BCAAs (via BCKDK inhibition) improves insulin sensitivity. While BT2 is a drug, the findings support the idea that managing BCAA metabolism is key to treating obesity-related metabolic issues.

Reducing dietary protein intake (specifically BCAAs) improves insulin sensitivity in obese mice, whereas increasing BCAA intake exacerbates insulin resistance.

For obese individuals, reducing the intake of branched-chain amino acids (found in high-protein foods like meat, eggs, and dairy) may improve insulin sensitivity. Conversely, high BCAA intake can worsen insulin resistance. This suggests that the quality of protein (BCAA content) is as important as the quantity.

Elevated levels of branched-chain alpha-keto acids (BCKAs) impair insulin signaling by activating mTORC1, independent of BCAAs.

BCKAs, metabolites of BCAAs, directly impair insulin signaling by activating mTORC1. This suggests that managing BCAA metabolism is crucial for preventing insulin resistance, as BCKAs are not just inert byproducts but active contributors to metabolic dysfunction.

Chronic tissue inflammation, driven by obesity-induced macrophage accumulation and proinflammatory cytokine release, is a major etiologic cause of insulin resistance and beta-cell dysfunction in metabolic disease.

In obesity, fat tissue doesn't just store energy; it becomes inflamed, releasing chemicals that block insulin from working properly in your muscles, liver, and pancreas. This inflammation is a direct cause of Type 2 Diabetes risk. Managing metabolic health requires addressing this underlying inflammatory state, not just caloric intake.

Chronic inflammation in pancreatic islets, driven by macrophage infiltration and proinflammatory cytokines (IL-1β, IL-23, IL-24), causes beta-cell dysfunction and reduced glucose-stimulated insulin secretion (GSIS) in Type 2 Diabetes.

In Type 2 Diabetes, inflammation inside the pancreas damages the insulin-producing beta cells. This isn't just about insulin resistance; the pancreas itself gets inflamed, reducing its ability to secrete insulin when needed. Protecting beta cells from inflammation is a key therapeutic target.

Growth Hormone (GH) injections do not increase muscle strength in sarcopenic patients and are associated with frequent side effects.

Do not use Growth Hormone injections to treat sarcopenia. They do not improve strength and cause side effects. Focus on exercise instead.

Ultra-marathon running can lead to temporary pathological changes in organ systems, including the heart, liver, kidneys, and immune system, which typically normalize after the race.

Don't panic if you feel unwell or see abnormal blood work after an ultra-marathon. The paper notes that changes in heart, liver, and kidney biomarkers are common but usually temporary and normalize after recovery. Focus on rest and hydration to allow your body to heal.

The protein content of microalgae varies significantly (6-71% of dry matter) and is heavily influenced by environmental factors such as light intensity, temperature, CO2 concentration, and nutrient availability.

When choosing microalgal products, be aware that protein content can vary widely depending on how the algae were grown. Look for products that specify their protein content, as this can range from 6% to over 70% of dry weight depending on cultivation conditions.

Advanced paternal age is associated with decreased sperm parameters (except concentration), increased DNA fragmentation, and higher risk of genetic disorders in offspring.

As men age, sperm quality declines, DNA fragmentation increases, and the risk of genetic disorders in children rises. Couples with advanced paternal age should be counseled cautiously regarding ART success rates and potential genetic risks.

Standard diagnostic tests (fasting glucose, HbA1c, OGTT) fail to identify glucose dysregulation in a significant subset of individuals classified as normoglycemic, who exhibit severe postprandial glucose variability and spikes into prediabetic/diabetic ranges when monitored via continuous glucose monitoring (CGM).

Standard blood tests (A1C, fasting glucose) can miss hidden glucose spikes. If you are 'normal' on labs but have risk factors, consider Continuous Glucose Monitoring (CGM) or standardized meal challenges to see how your body actually responds to food. This can reveal 'severe glucotypes' that indicate higher risk for diabetes and heart disease despite normal static labs.

Neck circumference (NC) is uniquely associated with the prevalence of common carotid artery (CCA) plaque in diabetic adults, independent of other abdominal obesity indices.

Measuring neck circumference is a simple, low-cost screening tool for diabetic patients to assess the risk of carotid artery plaque. Clinicians should incorporate NC measurements into routine diabetes care to identify patients at higher risk for vascular complications, especially since it provides unique information not captured by waist circumference or BMI.

Chronic hyperglycemia induces oxidative stress via multiple metabolic pathways (polyol, AGE, PKC, hexosamine), which directly causes insulin resistance and beta-cell dysfunction, leading to Type 2 Diabetes.

Managing blood sugar levels is critical not just for immediate comfort, but to prevent the cellular oxidative stress that drives long-term complications like nerve and kidney damage. Focus on dietary strategies that minimize glucose spikes to reduce the metabolic burden on your cells.

There is no significant association between the frequency of consuming home-cooked meals and markers of cholesterol, HbA1c, or hypertension after adjusting for sociodemographic and dietary covariates.

Do not expect home-cooked meals to directly improve cholesterol, HbA1c, or blood pressure levels based on this study alone, as these markers were not significantly associated with meal frequency after adjusting for other factors.

The presence of uncultured gut bacteria encoding the ismA gene (cholesterol dehydrogenase) metabolizes intestinal cholesterol into coprostanol, which is poorly absorbed, thereby significantly reducing both fecal and serum total cholesterol levels in humans.

This paper identifies a specific group of gut bacteria (encoding the ismA gene) that converts cholesterol into a form (coprostanol) that your body doesn't absorb, lowering your blood cholesterol. The effect is as strong as your genetic predisposition. While you cannot currently prescribe these specific uncultured bacteria, this highlights that your gut microbiome is a key lever for heart health. Future interventions may target these bacteria to lower cholesterol without drugs.

Among US adults, non-Hispanic Black individuals exhibited a significant decrease in lean body mass from 2011 to 2018, while other racial/ethnic groups maintained stable or increased lean mass.

For non-Hispanic Black adults, population data indicates a concerning trend of declining lean mass. To counter this, prioritize resistance training and adequate protein intake, as these are the primary levers for maintaining muscle mass, regardless of broader demographic trends.

The gut bacterium Eubacterium rectale causally decreases plasma levels of hydrogen sulfite, a toxin that negatively affects cardiovascular function.

Maintaining a healthy gut microbiome, specifically by supporting bacteria like Eubacterium rectale, may help reduce hydrogen sulfite levels in your blood, which is beneficial for cardiovascular health.

In Korean adults aged 30 and older, diabetes prevalence is 13.7% (4.8 million) and impaired fasting glucose (prediabetes) prevalence is 24.8% (8.3 million), with prevalence increasing significantly with age and lower family income.

If you are over 30, your risk of diabetes or prediabetes is significant, especially if you have lower income. Get screened regularly. Prediabetes (IFG) is highly prevalent and is a warning sign that lifestyle changes can prevent progression to full diabetes.

Despite high rates of medical treatment (89.1% of diagnosed diabetics), glycemic control remains poor, with only 23.3% achieving the target HbA1c <6.5% and 43.5% achieving <7.0%.

Just because you are taking diabetes medication doesn't mean your blood sugar is under control. Only about 1 in 4 people achieve the strict target of HbA1c <6.5%. You need to check your HbA1c regularly to ensure your treatment plan is actually working.